Distinct effects of pramipexole on the proliferation of adult mouse sub-ventricular zone-derived cells and the appearance of a neuronal phenotype

Neuropharmacology

Volumn 60, Issue 6, 2011, Pages 892-900

  Merlo, Sara ^a   Canonico, Pier Luigi ^b   Sortino, Maria Angela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Dopamine receptors; Neurodifferentiation; Neurospheres

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; BROXURIDINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOUBLECORTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; PRAMIPEXOLE; SULPIRIDE;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TARGETING; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBVENTRICULAR ZONE;

ANIMALS; BENZOTHIAZOLES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; DOPAMINE AGONISTS; GLIAL FIBRILLARY ACIDIC PROTEIN; INDANS; MALE; MICE; MICE, INBRED STRAINS; MICROTUBULE-ASSOCIATED PROTEINS; NEUROGENESIS; NEURONS; NEUROPEPTIDES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SULPIRIDE;

EID: 79952445045     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.01.026     Document Type: Article

References (40)

1. K.Y. Araki, J.R. Sims, and P.G. Bhide Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and post-natal development Brain Res. 1156 2007 31 45 (Pubitemid 46920516)
2. O. Arias-Carrion, N. Freundlieb, W.H. Oertel, and G.U. Hoglinger Adult neurogenesis and Parkinson's disease CNS Neurol. Disord. Drug Targets 6 2007 326 335 (Pubitemid 351486260)
3. A. Arvidsson, T. Collin, D. Kirik, Z. Kokaia, and O. Lindvall Neuronal replacement from endogenous precursors in the adult brain after stroke Nat. Med. 8 2002 963 970 (Pubitemid 35033700)
4. S.A. Baker, K.A. Baker, and T. Hagg Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone Eur. J. Neurosci. 20 2004 575 579 (Pubitemid 38969643)
5. P. Barone, W. Poewe, S. Albrecht, C. Debieuvre, D. Massey, O. Rascol, E. Tolosa, and D. Weintraub Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial Lancet Neurol 9 2010 573 580
6. K.G. Bath, and F.S. Lee Neurotrophic factor control of adult SVZ neurogenesis Dev. Neurobiol. 70 2010 339 349
7. M.E. Breuer, L. Groenink, R.S. Oosting, E. Buerger, M. Korte, B. Ferger, and B. Olivier Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats Eur. J. Pharmacol. 616 2009 134 140
8. S. Chiaramello, G. Dalmasso, L. Bezin, D. Marcel, F. Jourdan, P. Peretto, A. Fasolo, and S. De Marchis BDNF/ TrkB interaction regulates migration of SVZ precursor cells via PI3-K and MAP-K signalling pathways Eur. J. Neurosci. 26 2007 1780 1790 (Pubitemid 47493201)
9. V. Coronas, K. Bantubungi, J. Fombonne, S. Krantic, S.N. Schiffmann, and M. Roger Dopamine D3 receptor stimulation promotes the proliferation of cells derived from the post-natal subventricular zone J. Neurochem. 91 2004 1292 1301 (Pubitemid 39658556)
10. J. Diaz, S. Ridray, V. Mignon, N. Griffon, J.C. Schwartz, and P. Sokoloff Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain J. Neurosci. 17 1997 4282 4292 (Pubitemid 27220619)
11. F. Doetsch, I. Caille, D.A. Lim, J.M. Garcia-Verdugo, and A. Alvarez-Buylla Sub-ventricular zone astrocytes are neural stem cells in the adult mammalian brain Cell 97 1999 703 716 (Pubitemid 29278045)
12. F. Du, R. Li, Y. Huang, X. Li, and W. Le Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons Eur. J. Neurosci. 22 2005 2422 2430 (Pubitemid 41758985)
13. N. Freundlieb, C. Francois, D. Tande, W.H. Oertel, E.C. Hirsch, and G.U. Hoglinger Dopaminergic substantia nigra neurons project topographically organized to the sub-ventricular zone and stimulate precursor cell proliferation in aged primates J. Neurosci. 26 2006 2321 2325 (Pubitemid 44699041)
14. D.A. Gallagher, and A.H. Schapira Etiopathogenesis and treatment of Parkinson's disease Curr. Top. Med. Chem. 9 2009 860 868
15. M. Guttman, and J. Jaskolka The use of pramipexole in Parkinson's disease: are its actions D(3) mediated? Parkinsonism Relat. Disord. 7 2001 231 234 (Pubitemid 32372504)
16. G.U. Hoglinger, P. Rizk, M.P. Muriel, C. Duyckaerts, W.H. Oertel, I. Caille, and E.C. Hirsch Dopamine depletion impairs precursor cell proliferation in Parkinson disease Nat. Neurosci. 7 2004 726 735 (Pubitemid 38859057)
17. J.P. Hubble Pre-clinical studies of pramipexole: clinical relevance Eur. J. Neurol. 7 Suppl 1 2000 15 20 (Pubitemid 32260557)
18. K. Imamura, T. Takeshima, K. Nakaso, S. Ito, and K. Nakashima Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity Neurosci. Lett. 440 2008 97 102
19. M.M. Iravani, C.O. Haddon, J.M. Cooper, P. Jenner, and A.H. Schapira Pramipexole protects against MPTP toxicity in non-human primates J. Neurochem. 96 2006 1315 1321
20. O. Islam, T.X. Loo, and K. Heese Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways Curr. Neurovasc. Res. 6 2009 42 53
21. J.N. Joyce, and M.J. Millan Dopamine D3 receptor agonists for protection and repair in Parkinson's disease Curr. Opin. Pharmacol. 7 2007 100 105 (Pubitemid 46238043)
22. O. Kano, K. Ikeda, T. Kiyozuka, K. Iwamoto, H. Ito, Y. Kawase, R. Sato, T. Fujioka, Y. Araki, S. Baba, and Y. Iwasaki Beneficial effect of pramipexole for motor function and depression in Parkinson's disease Neuropsychiatr. Dis. Treat. 4 2008 707 710
23. G. Keilhoff, A. Becker, G. Grecksch, H.G. Bernstein, and G. Wolf Cell proliferation is influenced by bulbectomy and normalized by imipramine treatment in a region-specific manner Neuropsychopharmacology 31 2006 1165 1176 (Pubitemid 43971834)
24. Y. Kim, W.Z. Wang, I. Comte, E. Pastrana, P.B. Tran, J. Brown, R.J. Miller, F. Doetsch, Z. Molnar, and F.G. Szele Dopamine stimulation of postnatal murine subventricular zone neurogenesis via the D3 receptor J. Neurochem. 2010
25. T.E. Kippin, S. Kapur, and D. van der Kooy Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs J. Neurosci. 25 2005 5815 5823 (Pubitemid 40847894)
26. T. Kvernmo, J. Houben, and I. Sylte Receptor-binding and pharmacokinetic properties of dopaminergic agonists Curr. Top. Med. Chem. 8 2008 1049 1067
27. A.E. Lang The progression of Parkinson disease: a hypothesis Neurology 68 2007 948 952 (Pubitemid 46568509)
28. C. Leventhal, S. Rafii, D. Rafii, A. Shahar, and S.A. Goldman Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma Mol. Cell Neurosci. 13 1999 450 464 (Pubitemid 29337211)
29. J. Milosevic, S.C. Schwarz, M. Maisel, M. Poppe-Wagner, M.T. Dieterlen, A. Storch, and J. Schwarz Dopamine D2/D3 receptor stimulation fails to promote dopaminergic neurogenesis of murine and human midbrain-derived neural precursor cells in vitro Stem Cells Dev. 16 2007 625 635 (Pubitemid 47378735)
30. P. Mohapel, and P. Brundin Harnessing endogenous stem cells to treat neurodegenerative disorders of the basal ganglia Parkinsonism Relat. Disord. 10 2004 259 264 (Pubitemid 38757805)
31. G.C. O'Keeffe, R.A. Barker, and M.A. Caldwell Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain Cell Cycle 8 2009 2888 2894
32. G.C. O'Keeffe, P. Tyers, D. Aarsland, J.W. Dalley, R.A. Barker, and M.A. Caldwell Dopamine-induced proliferation of adult neural precursor cells in the mammalian sub-ventricular zone is mediated through EGF Proc. Natl. Acad. Sci. U S A 106 2009 8754 8759
33. ParkinsonStudyGroup Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression JAMA 287 2002 1653 1661
34. M.F. Piercey Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease Clin. Neuropharmacol 21 1998 141 151 (Pubitemid 28248773)
35. S.P. Presgraves, S. Borwege, M.J. Millan, and J.N. Joyce Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells Exp. Neurol. 190 2004 157 170 (Pubitemid 39335715)
36. M. Snapyan, M. Lemasson, M.S. Brill, M. Blais, M. Massouh, J. Ninkovic, C. Gravel, F. Berthod, M. Gotz, P.A. Barker, A. Parent, and A. Saghatelyan Vasculature guides migrating neuronal precursors in the adult mammalian forebrain via brain-derived neurotrophic factor signaling J. Neurosci. 29 2009 4172 4188
37. J.M. Van Kampen, T. Hagg, and H.A. Robertson Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D3 receptor stimulation Eur. J. Neurosci. 19 2004 2377 2387 (Pubitemid 38621836)
38. J.M. Van Kampen, and H.A. Robertson A possible role for dopamine D3 receptor stimulation in the induction of neurogenesis in the adult rat substantia nigra Neuroscience 136 2005 381 386 (Pubitemid 41607886)
39. B. Winner, S. Couillard-Despres, M. Geyer, R. Aigner, U. Bogdahn, L. Aigner, H.G. Kuhn, and J. Winkler Dopaminergic lesion enhances growth factor-induced striatal neuroblast migration J. Neuropathol. Exp. Neurol. 67 2008 105 116
40. B. Winner, P. Desplats, C. Hagl, J. Klucken, R. Aigner, S. Ploetz, J. Laemke, A. Karl, L. Aigner, E. Masliah, E. Buerger, and J. Winkler Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model Exp. Neurol. 219 2009 543 552